Corporate Counsel Approved Press Release
OKLAHOMA CITY, OK, August 12, 1999
PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (OTC BB: PDRX) today announced the addition of remote wireless electronic prescribing utilizing a Handheld PC device running the popular Windows" CE operating system. The Handheld PC has wireless (non-docking) connectivity to the Companys proprietary Rx-Net System Communication Network. The Company has completed its research and development and Beta testing begins immediately. Dr. Robert Holsey, CEO, stated, “This new technology will further the Company’s long term commitment to providing physicians with a point of care interface designed to promote patient education and offer a technology-based approach to cost effective pharmaceutical healthcare delivery.”
Our products are designed to streamline the pharmaceutical healthcare delivery paradigm. We currently offer products in five categories: point of care electronic medication triage, Internet services, patient education products, medical/surgical supplies and prepackaged medication. Our Rx-Net System is a software/hardware communication network that provides physicians the capabilities to interact and network with traditional and non-traditional pharmacy delivery systems. It allows electronic prescribing, routing of prescription information and capturing of prescription data at the point of care. We also sell our prepackaged medications to physicians so they can offer their patients the convenience and confidentiality of receiving prescription medications in the privacy of the physician’s office.
This press release contains ``forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks and uncertainties or other factors, which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to vary from those forecast or implied in this release. Factors that might cause such a difference include, without limitation, decline in demand for the company's products or services, and the effect of general economic conditions and factors affecting the industry.
PD-Rx
Pharmaceuticals, Inc.
Investor Relations:
Jack
McCall
(405)942-3040